vaso8knov14-2011.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
 
FORM 8-K
 
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report:  November 14, 2011
(Date of earliest event reported)

VASOMEDICAL, INC.
(Exact name of registrant as specified in its charter)

Delaware
0-18105
11-2871434
(State or other jurisdiction
(Commission File
(IRS Employer
of incorporation)
Number)
Identification No.)

180 Linden Avenue, Westbury, New York
11590
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code:                                                                                     (516) 997-4600

_________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement to communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
 

Item 5.07                      Submission of Matters to a Vote of Security Holders
 
 
(a)
The Registrant held its Annual Meeting of Stockholders on November 14, 2011.
 
 
(b)
(i)
The seven nominated directors were elected, receiving the following votes:
 
 
Votes For
Votes Withheld
Class I
    
Edgar Rios
81,911,759
8,617,562
William Dempsey
78,126,400
12,402,921
     
Class II
    
Behnam Movaseghi
88,537,785
1,991,537
Peter C. Castle
89,691,673
837,648
     
Class III
    
Simon Srybnik
90,117,194
412,127
Jun Ma
88,552,816
1,976,505
David Lieberman
87,869,508
2,659,813
 

 
 
(ii)
The proposal to ratify the appointment of Rothstein, Kass & Company, P.C. as the Company’s independent registered public accountants for the year ending December 31, 2011, as set forth in the proxy statement was approved as follows:
 
Votes For
Votes Against
Votes Abstain
130,025,370
1,148,561
347,718

 

 

 


 
 
 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:   November 16, 2011
VASOMEDICAL, INC.
By:    /s/ Michael J. Beecher
Michael J. Beecher
Chief Financial Officer